Programme : Back to Dr Emma Shanks

Academic Drug Discovery within the UK - a reassessment


In 2014, Tralau-Stewart et al [1] published an account of academic screening undertakings within the UK, written to reflect responses received to a circulated questionnaire. In many ways, this represented an accurate depiction of academic screening at the time. However, their findings also highlighted that:
1) academic screening was conducted in 'traditional' research groups, with only 13% operating in a dedicated facility
2) “access to HTS facilities and associated compound libraries was not reported by any UK group” [1]

Centre-led academic screening groups and industry standard drug discovery programmes conducted within an academic environment in the UK has, to date, been grossly understated. We present a comprehensive representation of Academic Screening Groups and Drug Discovery Units within the UK [2].

[1] Tralau-Stewart, C., C.M.R. Low, and N. Marlin, UK academic drug discovery. Nat Rev Drug Discov, 2014. 13(1): p. 15-16.
[2] Shanks, E., Ketteler, R., Ebner, D, Academic Drug Discovery within the UK - a reassessment. Nat Rev Drug Discov, 2015 (in press)
Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018